Pinnacle Financial Partners »

Syndax Pharmaceuticals shares owned by Pinnacle Financial Partners

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Pinnacle Financial Partners from 13F filings

Historical chart of Pinnacle Financial Partners investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Pinnacle Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Pinnacle Financial Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.3M 207k 21.01

More positions owned by Pinnacle Financial Partners

Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Rus 1000 Grw Etf (IWF)
Global Payments (GPN)
Coca-Cola Company (KO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Synovus Finl Corp Com New (SNV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Pinnacle Financial Partners

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Vanguard Group
Goldman Sachs Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Hood River Capital Management
Soleus Capital Management
Geode Capital Management
Ensign Peak Advisors
Nuveen

View all funds holding Syndax Pharmaceuticals